Skip to main content
Clinical Trials/JPRN-UMIN000042765
JPRN-UMIN000042765
Recruiting
未知

In vivo imaging of distribution of serotonin 1B receptor and synaptic density in autism spectrum disorder: a case-control comparison with positron emission tomography. - In vivo imaging of serotonin 1B receptor and synaptic density in ASD using PET.

Hamamatsu University School of Medicine0 sites60 target enrollmentDecember 17, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
Autism spectrum disorder
Sponsor
Hamamatsu University School of Medicine
Enrollment
60
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 17, 2020
End Date
October 31, 2025
Last Updated
2 years ago
Study Type
Observational
Sex
Male

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Current or past medical histories of brain organic diseases. 2\) Comorbidity of substance\-related disorders. 3\) Contraindications on MRI scanning. 4\) For the case of typically developing subjects, current or past medical histories of psychiatric disease.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Imaging serotonin transmission in the brain of depressed patients.Major depressive disorder, Adjustment disorder with depression
JPRN-UMIN000012050ational Institute of Radiological Sciences60
Active, not recruiting
Not Applicable
ongitudinal imaging of serotonin transporter occupancy using PET and [11C]DASB in patients with major depression treated with escitalopram or citalopram - PET with DASB comparing escitalopram to citalopramMajor depression
EUCTR2006-006576-38-ATSiegfried KASPER, O.Univ.Prof.Dr.Dr.h.c., Medizinische Universität Wien
Completed
Not Applicable
PET study of the density ratio of the serotonin 2A receptors and D2 receptors in the each subregions of the prefrontal cortexHealthy
JPRN-UMIN000013798ational Institute of Radiological Sciences12
Recruiting
Not Applicable
A PET study of serotonin transporter, activated microglia and energy metabolism measerment of the brain in Chronic Fatigue Syndrome.Chronic Fatigue Syndrome
JPRN-UMIN000005469Department of Metabolism, Endocrinology and Molecular Medicine, Osaka City University Graduated School of Medicine48
Completed
Not Applicable
In-vivo-quantification of both serotonin-and norepinephrin-transporter availability in obese persons without co-morbid depression using positron emission tomography (PET) and selective radio-labelled markers - comparison with healthy controls and 6 months after a multimodal treatment programeating behaviour, eating disordersE66Obesity
DRKS00003537niversitätsklinikum Leipzig AöRKlinik und Poliklinik für Nuklearmedizin65